SUPN
Supernus Pharmaceuticals Inc
Price:  
27.51 
USD
Volume:  
453,220.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN Probability of Bankruptcy

The Probability of Bankruptcy of Supernus Pharmaceuticals Inc (SUPN) is 5.95% . This number represents the probability that SUPN will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating SUPN's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

SUPN - ESG ratings

ESG ratings are directly linked to the cost of capital and SUPN's ability to raise funding, both of which can significantly affect the probability of Supernus Pharmaceuticals Inc going bankrupt.

ESG Score 40.03
Environment Score 43.44
Social Score 41.05
Governance Score 35.60
Returns
Historical Returns (5 day) -4.38%
Historical Returns (MTD) -8.60%
Historical Returns (YTD) -4.94%
Historical Returns (13 week) -5.33%
Historical Returns (26 week) 0.29%
Historical Returns (52 week) -17.98%
Efficiency
Asset Turnover 0.46
Receiveable Turnover 4.10
Gross Margin 88.65%
Operating Margin -2.20%
Pretax Margin 0.17%
Net Margin 0.09%
Return on Asset (ROA) -1.20
Return on Equity (ROE) -1.68
Return on Investments (ROI) -1.68
Price Metrics
Market Cap (M) 1,512.22
Enterprise Value (M)
52 Week High 35.93
52 Week Low 22.00
Beta 0.83
Average Volume (10 day) 0.35
Average Volume (3 month) 0.18
Price / Earnings (P/E)
Price / Sales (P/S) 2.53
Earnings
EPS -0.28
Revenue CAGR (5 year) 8.24%
Risk
Current Ratio 1.73
Quick Ratio 1.42